We tested two positive selection techniques for separation of CD34 + cells from bone marrow and analyzed the yields of CD34 + cells, BFU-E, CFU-GM, CFU-MK and LTC-IC after selection and expansion. An immunoadsorption procedure (CellPro) and an immunomagnetic (Baxter) CD34
employed. 1 Our objective was to compare the phenotypic profile and clonogeneic capacity before and after expansion of cells selected by immunoadsorption 2 or using an immunomagnetic system. 3 These two commercial systems are, to date, the most widely employed in a variety of clinical settings. Until now, all teams who compared different selection techniques used different samples for each technique. 4, 5 Thus, in the present study, the same bone marrow sample was used simultaneously for both CD34
+ cell separation methods while, in addition, the expansion capacity of the selected cells was investigated in liquid cultures.
Materials and methods

Bone marrow (BM) cell preparation
BM cells were obtained from patients undergoing hip surgery, all of whom gave informed consent for BM cell donation. Light-density mononuclear cells (MNCs) were separated on a Ficoll-Isopaque density gradient (1.077 g/ml; Seromed, Biochrom, Berlin, Germany). MNCs were washed twice and the cell concentration was adjusted to 0.5-1 × 10 8 /ml in Ca-and Mg-free PBS (Gibco, Life Technologies, Paisley, UK) supplemented with 1% bovine serum albumin (BSA) provided by CellPro. After mixing, MNCs were divided into two equal samples for simultaneous purification of CD34 + cells using the two different methods.
CD34
+ cell purification by immunoadsorption CD34 + cells were positively selected on an avidin/biotin affinity column (CEPRATE, CellPro, Bothell, WA, USA) according to the manufacturer's instructions. Briefly, MNCs were incubated with 20 g/ml of a biotinylated mAb (12.8; IgM) for 25 min at room temperature, washed twice and filtered through the Ceprate avidin column. After washing the column to remove nonspecifically bound cells, CD34
+ cells were released from the avidin beads by mechanical agitation.
+ cell purification by immunomagnetism CD34 + cells were separated according to the manufacturer's recommendations (Baxter Fenwal Division, Deerfield, IL, USA). Briefly, MNCs were incubated for 15 min at room temperature in a rocker-rotator with an anti-human CD34 mAb (9C5) at a concentration of 0.5 mg/10 6 MNCs. The cells were washed, mixed with sheep anti-mouse IgG1-Fc coated paramagnetic beads (Dynal, Oslo, Norway) at a ratio of two cells per bead, for 30 min at room temperature and isolated using a magnetic tube holder. Detachment of CD34 + cells from the beads was performed either by treatment with 100 U/ml chymopapain (ChimoCell; Baxter) in experiments 5 to 7 or by competitive elution using a specific peptide (PR34+TM, Baxter) in experiments 1 to 4.
Liquid cultures
To culture CD34
+ cells in the liquid phase, 2500 cells per well were suspended in six-well plates (Falcon, Heidelberg, Germany) in 1.5 ml of a mixture containing long-term culture medium (LTCM) and cytokines. Cultures were incubated at 37°C in a 100% humidified 5% CO 2 atmosphere for 10 days. After refeeding on day 6, cells were collected on day 10, washed in Iscove's modified Dulbecco's medium (IMDM; Seromed, Biochrom), counted by trypan blue exclusion and then assayed for progenitor cells, LTC-IC and immunophenotype. LTCM was prepared from IMDM by supplementing with 10 g/ml folic acid (F7876; Sigma, St Louis, MO, USA), 2.6 mm l-glutamine (Gibco), 1.5 U/ml heparin (Fournier, Gennevilliers, France), 10 −6 m hydrocortisone hemisuccinate (Sigma), 1.6 × 10 −4 m monothioglycerol (Sigma), 40 g/ml inositol (I5125; Sigma), 40 U/ml penicillin and 40 g/ml streptomycin (Gibco). LTCM was further supplemented with 5 mg/ml BSA (A4503; Sigma), 150 g/ml iron saturated human transferrin (T7786; Sigma), 100 g/ml recombinant insulin (I0259; Sigma), 30 g/ml soybean lecithin (L3782; Sigma) and 7.5 g/ml cholesterol (C3045; Sigma) according to our previously described technique.
6,7
Cytokines
Cultures were stimulated with the following recombinant human growth factors: IL3 (5 ng/ml, specific activity: 8.2 × 10 6 U/mg; Sandoz, Basel, Switzerland), IL6 (10 ng/ml, specific activity: 52 × 10 6 U/mg; Sandoz), FLT3 (100 ng/ml; Immunex, Seattle, WA, USA), MGF (100 ng/ml, specific activity: 2.6 × 10 6 U/mg; Immunex), G-CSF (10 ng/ml; Chugai Rhone Poulenc, Ukima, Japan), and Epo (0.5 U/ml, specific activity: 173 000 U/mg protein; Boehringer Mannheim, Mannheim, Germany).
BFU-E and CFU-GM assays
BFU-E and CFU-GM were assayed in single-layer methylcellulose cultures according to Eaves et al. 8 Cells were plated in duplicate 35-mm tissue culture dishes (Falcon), in 1 ml aliquots of IMDM supplemented with 1% BSA, 30% FCS, 2 mm l-glutamine, 10 −4 m (beta) mercaptoethanol (Sigma), 20 ng/ml GM-CSF (specific activity: 1.5 × 10 7 CFU/mg; Behring, Marburg, Germany), 20 ng/ml G-CSF, 10 ng/ml IL3, 3 U/ml Epo, 50 ng/ml MGF and 0.92% methylcellulose (Fluka, Buchs, Switzerland). Cell concentrations were 0.5-1 × 10 4 MNC/ml and 0.5-1 × 10 3 CD34 + cells/ml at day 0 and 2 × 10 3 -5 × 10 4 cells/ml on day 10 according to the number of cells recovered. Cultures were incubated at 37°C in a fully humidified 5% CO 2 atmosphere and BFU-E and CFU-GM were scored on day 14 of culture.
CFU-MK assays
CFU-MK assays were performed by plating cells in a plasma clot culture system according to Mitjavila et al. 9 The culture medium was IMDM containing 10% preselected serum from aplastic patients, 1% BSA, 20 g/ml lasparagine, 28 g/ml CaCl 2 , 10% citrated bovine plasma (Gibco), 20 ng/ml IL3, 20 ng/ml IL6 and 100 ng/ml MGF. Cell concentrations were 2 × 10 5 MNC/ml and 10 4 CD34
+ cells/ml at day 0 and 2-5 × 10 5 cells/ml on day 10. Clots were dried in situ, fixed in methanol and allowed to react for 30 min with a CD61 (GpIIIa) mAb (Immunotech, Marseille, France), binding of the mAb being revealed using 1:100 diluted mouse IgG + IgM F(abЈ) 2 coupled to alkaline phosphatase (Caltag Lab, San Francisco, CA, USA). Counterstaining of the clots was performed with hematoxylin and colonies containing three or more cells were scored on day 12 of culture.
Long-term bone marrow culture-initiating cells (LTC-IC) in a limiting dilution assay
Preformed stroma layers were established using the MS5 murine cell line generously provided by K Mori (Department of Biology, Faculty of Science, Niigata, Japan). The cell line was suspended in 5 ml of MEM (Gibco, France) supplemented with 10% FCS (Biosys, Compiègne, France) in 25 cm 2 tissue culture flasks and the cultures were fed until confluence. Adherent cells were then trypsinized (Gibco) and replated into 1% gelatin coated 96-well plates. On days 0 and 10 of culture, cells were seeded onto the preformed feeder. Cultures were initiated in LTCM medium supplemented with 12.5% FCS and 12.5% HS and fed weekly by replacing half the medium. After 5 weeks of culture, the progenitor content of each well was scored by overlaying the wells with methylcellulose medium containing MGF, IL3, G-CSF, GM-CSF and Epo as described above. The incidence of LTC-IC was determined by scaling the cultures down to a volume of 100 l in the 96-well microtiter plates and performing cell counts at limiting dilution with 20 to 50 replicates per dilution step. Dilution steps were 100, 50, 25, 10 and 5 cells/well for the CD34 + cell fraction and 20000, 10000, 4000, 1000 and 500 cells/well for expanded populations. The frequency of negative wells was also determined, and the frequency of LTC-IC was calculated by Poisson statistics, using iterative procedures to determine the best linear fit and standard errors of this function.
Flow cytometry
Initial and cultured cell populations were evaluated for expression of CD34 (HPCA-2, IgG1, PerCP), CD38 (Leu17, IgG1, FITC) and CD33 (My 9, IgG1, PE). All mAbs were purchased from Becton Dickinson (BD, San José, CA, USA). Isotype-matched control antibodies were 
Data analysis
The total number of cells and the number of CD34 + cells per well on day 10 were divided by the number of cells in the liquid culture at day 0. To determine baseline progenitor cells, the number of colonies generated at day 0 was adjusted to the same number of cells. At day 10, expansion was calculated by dividing the number of 
Results
Although no statistical calculation could be performed due to the low number of experiments, there was no apparent difference between the two immunomagnetic techniques employing either chymopapain or PR34 for CD34 + cell detachment. In addition, the results of the two immunomagnetic techniques compared similarly with those of immunoadsorption. Hence, the data obtained by the immunoadsorption technique will be compared with those obtained by the two immunomagnetic techniques taken together.
FACS study of cell populations selected by the two methods
FACS analyses in seven experiments (mean Ϯ s.d.) showed the MNC fraction before positive selection to contain 3.5 Ϯ 1.7% (range 1.5-6.1%) CD34
+ cells. The mean clonogenic efficiency of the starting population was 340 Ϯ 240 BFU-E, 710 Ϯ 300 CFU-GM and 11 Ϯ 5.6 CFU-MK for 10 5 MNC. After selection, the purity of CD34 + cells (mean Ϯ s.d.) was 87 Ϯ 10% using the immunoadsorption technique and 80 Ϯ 19% using the immunomagnetic technique. CD34
+ recovery (mean Ϯ s.d.) from the initial population was respectively 40 Ϯ 17.8% and 44 Ϯ 7.8% using the immunoadsorption and immunomagnetic methods, while the mean percentages of the CD34 + /CD33 + and CD34 + /CD38 − subpopulations were similar in both cases. However, wide variations in either direction were noted in individual experiments (Table 1) .
Precursor, progenitor and LTC-IC recoveries
Over seven experiments, the percentages (mean Ϯ s.d.) of nucleated cells recovered after immunoadsorption and immunomagnetic separations were respectively 1.48 Ϯ 0.5% and 1.77 Ϯ 0.75% (Table 2 ). There were no significant differences due to separation technique concerning the mean yields of CFU-GM and CFU-MK or the absolute number of LTC-IC. However, it should be noted that the yield of CFU-MK was markedly different between the two methods in individual experiments, varying in apparently random fashion from one experiment to another and tending to depend on cell recovery ( Table 2 ). The mean yield of BFU-E was significantly lower for immunoadsorption (21 Ϯ 14%) than for immunomagnetic separation (44 Ϯ 27%) (P = 0.045). However, this was not consistent as the yield of BFU-E was higher after immunoadsorption in experiment 4 and equal for the two techniques in experiment 7. Interestingly, the yields of cells, CFU-GM and CFU-MK obtained by immunoadsorption were higher in these two experiments than those obtained by immunomagnetism.
Expansion of CD34 + purified cells
The expansion capacity of cells selected by immunoadsorption (1625 Ϯ 1084 fold) was similar to that of cells obtained by immunomagnetism (1733 Ϯ 1449 fold). In contrast, the expansion of progenitor cells in terms of CFU-GM, CFU-MK and especially BFU-E was higher in populations obtained by the immunoadsorption than in those purified by the immunomagnetic method ( Table 3 ). The conclusions were not affected when the number of cells and progenitors obtained after expansion of CD34 + cells isolated by the two techniques were analyzed with regard to the cells in the starting population of MNC rather than to the CD34 + -enriched cell populations. The relative number of cells was similar using immunoadsorption (2.8 × 
Discussion
The choice of CD34 + cell separation technique depends on the final destination of the purified cells. Factors such as yield, purity and clonogeneic capacity of the selected cells, time and cost need different emphasis for the various applications in clinical and research areas. Commercially available methods generate cell populations enriched in stem/progenitor cells having varying degrees of purity, yield and enrichment and we therefore compared two widely employed separation techniques in order to investigate possible differences in terms of the phenotype and functional capacity of cells selected from the same bone marrow samples.
Immunoadsorption selected similar numbers of stem/progenitor cells but lower numbers of erythroid progenitors as compared to the immunomagnetic method. Taking the two variants of the latter technique together, numbers of BFU-E were significantly different using immunoadsorption and immunomagnetism. The erythroid Results are expressed as fold increases (day 10 vs day 0). ND = not done; M = MGF; 3 = IL3; 6 = IL6; E = EPO; F = FLT3; G = G-CSF. Wilcoxon rank test: *P = 0.009; **P = 0.0045. − fractions for their BFU-E content. 11 However, in previous studies we consistently obtained almost the same low level of BFU-E recovery in CD34 + cell fractions selected by immunoadsorption. 7 The BFU-E recovery after purification by immunoadsorption of bone marrow cells from 13 patients (11 non-Hodgkin's lymphoma, one myeloma and one ALL) and three normal donors was significantly lower in CD34 + (30.6 Ϯ 14.8%) than in CD34
− fractions (52 Ϯ 20%) (P = 0.02). It was similar in the two fractions after purification by immunomagnetism of six bone marrow samples from normal donors (43 Ϯ 13% and 41 Ϯ 13%, respectively). Therefore, there seems to be a greater loss of BFU-E by immunoadsorption than by immunomagnetism. The recovery of CFU-GM was consistently higher in CD34
+ fraction than in CD34 − fraction regardless of the technique used. The respective recovery from the CD34 + and CD34
− fractions was 64 Ϯ 18% vs 18 Ϯ 17% for immunoadsorption and 46 Ϯ 41% vs 19 Ϯ 11% for the immunomagnetic technique (unpublished data). The low yield of BFU-E using immunoadsorption could not be confirmed by immunophenotyping. It has been reported that only the progenitors of BFU-E express high levels of the CD33 antigen, which decreases rapidly with erythroid maturation, 12 thus making the phenotypic discrimination of BFU-E with respect to CD33 difficult and contradictory. 13, 14 Recently, BFU-E were found to be concentrated within the CD71 ++ /gly A − cell subpopulation, 15, 16 not studied in our experiments.
Cells selected by immunoadsorption showed better expansion than those selected by immunomagnetism, possibly on account of one or both of two factors which may have influenced the expansion capacity of progenitors in our experiments. Firstly, low concentrations of progenitors expand better in liquid culture conditions due to more optimal nutritional conditions. In a previous study of the effects of CD34 + cell concentration on the expansion potential of the cells, 17 we observed an inverse correlation between number of cells per ml of culture medium and final expansion rate. However, the high expansion capacity of CFU-GM and CFU-MK from cells separated by immunoadsorption in the present experiments cannot be explained by the concentrations of these cells in the 10-day liquid cultures, as numbers of colonies if not of BFU-E were similar using the two separation techniques. Secondly, the progenitors selected by immunoadsorption may in reality have better expansion potential due to their immaturity or the presence of specific CD34 + subpopulations. In experiment 2, starting from the same number of cells before selection, we obtained two-fold more CFC from LTC-IC after expansion of the cells selected by immunoadsorption than after expansion of the immunomagnetic selected cells. Interestingly, the proportion of early primitive cells (CD34 + /CD38 − ) before expansion was also higher after immunoadsorption (9.4%) than after immunomagnetic separation (2.3%), which probably indicates a more primitive character. In fact, the immunomagnetic method uses a CD34 antibody of IgG isotype while immunoadsorption uses an antibody of IgM isotype. As the interactions of antibodies with the CD34 antigen tend to be of lower affinity for IgM than for IgG isotypes, 18 cells with low level CD34 expression, corresponding to already committed progenitors, could be lost during the immunoadsorption isolation procedures. Our data nevertheless do not support this alternative, since we obtained similar numbers of total and progenitor cells using either separation method except in the case of erythroid progenitors.
The selection procedure employed to obtain CD34 + cells from different sources is critical in both clinical and research applications. Since CD34 + cell purification is widely used in the initial stages of experiments, it is important to know which CD34 + subpopulations are selected by different techniques. In clinical transplantation, this may have a serious impact on graft reconstitution if the progenitors of some hematopoietic lineages are not represented. Although the two techniques evaluated in the present work gave similar results in terms of final cell population, it is noteworthy that the immunoadsorption technique yielded fewer BFU-E progenitors, whereas the expansion capacity of progenitors obtained by immunoadsorption was slightly higher than the capacity of cells obtained by immunomagnetism. These two methods are both useful in current clinical and/or research applications, but our findings indicate the need for carefully performed clinical studies to determine whether the use of different isolation systems could influence the recovery of different hematopoietic lineages.
